Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. - Deacon,C.F.; Johnsen,A.H.; Holst,J.J. (J Clin Endocrinol Metab, 1995)